When the world gets closer.

We help you see farther.

Sign up to our expressly international daily newsletter.

Already a subscriber? Log in.

You've reach your limit of free articles.

Get unlimited access to Worldcrunch

You can cancel anytime.

SUBSCRIBERS BENEFITS

Ad-free experience NEW

Exclusive international news coverage

Access to Worldcrunch archives

Monthly Access

30-day free trial, then $2.90 per month.

Annual Access BEST VALUE

$19.90 per year, save $14.90 compared to monthly billing.save $14.90.

Subscribe to Worldcrunch
LA STAMPA

Who Will Find It First? The Global Race For A Vaccine

Cooperation is important, but so is competition ... as research bodies and nations look to find the only true solution to the COVID-19 pandemic as quickly as possible.

Vaccines usually take years to discover
Vaccines usually take years to discover
Kat Bohmbach

PARIS — As the coronavirus continues to spread its deadly tracks via human contact at remarkable speeds, medical researchers are in a race against time to develop a vaccine to immunize the global population. But there are also races within that race: among private foundations and public health administrations — and from one country to the next. Yes both cooperation and competition are vital to get an effective vaccine as quickly as possible.

So far, the general consensus is that it will take at least 12 to 18 months to map out, test and produce an effective solution. In an effort to accelerate, Bill Gates said last week that the Bill and Melinda Gates Foundation is funding the construction of factories for the seven most-promising vaccine candidates. Only one vaccine will ultimately be chosen, while the remaining candidates most likely make it very far at all, shining a light on the tumultuous, arduous, and extremely costly road to developing a vaccine., Meanwhile on Tuesday, Russia announced that it will begin testing a vaccine on humans as soon as June. Here are some of the factors and projects that could be key to find a solution:

  • Cost & Scale: There are currently at least 35 companies and academic institutions working on the development of a vaccine. The cost is upwards of $2 billion, according to Le Monde, meaning that only large global laboratories and start-ups backed by foundations or companies can afford to try. Once a vaccine has been approved, Johnson & Johnson in the U.S has already made a $1 billion deal to produce more than a billion doses.

  • Sequence: China sent out the genetic sequence of COVID-19 in mid-January, giving researchers a head-start, but they still don't know how the virus will evolve or react to treatments.

  • Bird study: Les Echos visited researchers in Israel working to create vaccines based on "prototype" pathogens they had already been studying in birds, as well as monitoring the effects different medications have on COVID-19 patients.

  • Real time: Because it can take so long to map out a vaccine, doctors in Italy are helping to mobilize a first of its kind effort to share research, in real-time, 24-hours a day over social media, reports La Stampa.

  • Trials: Several companies, including Moderna, in the race for developing a vaccine will be pushing forward with human testing trials in the coming weeks. This does not mean that a cure for COVID-19 is a near-reality. Seth Berkley, head of the Vaccine Alliance, GAVI, cautions that it usually takes between 10 and 15 years for a drug to go from development to testing phases and onto licensing then manufacturing. The vaccine for Ebola was ready in 5 years. One of the lead researchers behind that effort said there are some signs of hope for quicker results for COVID-19.

You've reached your limit of free articles.

To read the full story, start your free trial today.

Get unlimited access. Cancel anytime.

Exclusive coverage from the world's top sources, in English for the first time.

Insights from the widest range of perspectives, languages and countries.

Green

Forest Networks? Revisiting The Science Of Trees And Funghi "Reaching Out"

A compelling story about how forest fungal networks communicate has garnered much public interest. Is any of it true?

Thomas Brail films the roots of a cut tree with his smartphone.

Arborist and conservationist Thomas Brail at a clearcutting near his hometown of Mazamet in the Tarn, France.

Melanie Jones, Jason Hoeksema, & Justine Karst

Over the past few years, a fascinating narrative about forests and fungi has captured the public imagination. It holds that the roots of neighboring trees can be connected by fungal filaments, forming massive underground networks that can span entire forests — a so-called wood-wide web. Through this web, the story goes, trees share carbon, water, and other nutrients, and even send chemical warnings of dangers such as insect attacks. The narrative — recounted in books, podcasts, TV series, documentaries, and news articles — has prompted some experts to rethink not only forest management but the relationships between self-interest and altruism in human society.

But is any of it true?

The three of us have studied forest fungi for our whole careers, and even we were surprised by some of the more extraordinary claims surfacing in the media about the wood-wide web. Thinking we had missed something, we thoroughly reviewed 26 field studies, including several of our own, that looked at the role fungal networks play in resource transfer in forests. What we found shows how easily confirmation bias, unchecked claims, and credulous news reporting can, over time, distort research findings beyond recognition. It should serve as a cautionary tale for scientists and journalists alike.

First, let’s be clear: Fungi do grow inside and on tree roots, forming a symbiosis called a mycorrhiza, or fungus-root. Mycorrhizae are essential for the normal growth of trees. Among other things, the fungi can take up from the soil, and transfer to the tree, nutrients that roots could not otherwise access. In return, fungi receive from the roots sugars they need to grow.

As fungal filaments spread out through forest soil, they will often, at least temporarily, physically connect the roots of two neighboring trees. The resulting system of interconnected tree roots is called a common mycorrhizal network, or CMN.

Keep reading...Show less

You've reached your limit of free articles.

To read the full story, start your free trial today.

Get unlimited access. Cancel anytime.

Exclusive coverage from the world's top sources, in English for the first time.

Insights from the widest range of perspectives, languages and countries.

Already a subscriber? Log in.

You've reach your limit of free articles.

Get unlimited access to Worldcrunch

You can cancel anytime.

SUBSCRIBERS BENEFITS

Ad-free experience NEW

Exclusive international news coverage

Access to Worldcrunch archives

Monthly Access

30-day free trial, then $2.90 per month.

Annual Access BEST VALUE

$19.90 per year, save $14.90 compared to monthly billing.save $14.90.

Subscribe to Worldcrunch

The latest